Impact of Intraoperative Cell Salvage on Blood Coagulation Factor Concentrations in Patients Undergoing Cardiac Surgery

Complement Suppression Drug Does Not Prevent Cognitive Decline After CABG

Treatment with pexelizumab, a monoclonal antibody against the C5 complement component, does not prevent the overall drop in cognition that can occur after coronary artery bypass grafting (CABG), new research shows.